Clinical Trials
3 trialsNCT03627988 2026-05-22
MARTA
Institut Claudius Regaud
Phase 2 Completed
NCT06695039 2025-12-02
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer
Asan Medical Center
Phase 2 Completed
NCT04398914 2022-03-31
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Active not recruiting